nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ORM1—Tacrolimus—atopic dermatitis	0.202	0.295	CbGbCtD
Vemurafenib—ALB—Tacrolimus—atopic dermatitis	0.0848	0.124	CbGbCtD
Vemurafenib—ABCG2—Hydrocortisone—atopic dermatitis	0.0501	0.0732	CbGbCtD
Vemurafenib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0447	0.0653	CbGbCtD
Vemurafenib—CYP1A2—Diphenhydramine—atopic dermatitis	0.0371	0.0543	CbGbCtD
Vemurafenib—ALB—Prednisone—atopic dermatitis	0.0344	0.0503	CbGbCtD
Vemurafenib—ABCG2—Dexamethasone—atopic dermatitis	0.0311	0.0455	CbGbCtD
Vemurafenib—CYP2D6—Loratadine—atopic dermatitis	0.0306	0.0447	CbGbCtD
Vemurafenib—CYP2D6—Diphenhydramine—atopic dermatitis	0.0306	0.0447	CbGbCtD
Vemurafenib—CYP3A4—Tacrolimus—atopic dermatitis	0.0266	0.0388	CbGbCtD
Vemurafenib—CYP3A4—Loratadine—atopic dermatitis	0.0195	0.0284	CbGbCtD
Vemurafenib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0178	0.026	CbGbCtD
Vemurafenib—CYP3A4—Triamcinolone—atopic dermatitis	0.0135	0.0197	CbGbCtD
Vemurafenib—CYP3A4—Betamethasone—atopic dermatitis	0.0116	0.0169	CbGbCtD
Vemurafenib—CYP3A4—Prednisolone—atopic dermatitis	0.0114	0.0167	CbGbCtD
Vemurafenib—CYP3A4—Hydrocortisone—atopic dermatitis	0.0108	0.0158	CbGbCtD
Vemurafenib—CYP3A4—Prednisone—atopic dermatitis	0.0108	0.0158	CbGbCtD
Vemurafenib—CYP2D6—Dexamethasone—atopic dermatitis	0.0106	0.0155	CbGbCtD
Vemurafenib—CYP3A4—Dexamethasone—atopic dermatitis	0.00673	0.00983	CbGbCtD
Vemurafenib—Malnutrition—Tacrolimus—atopic dermatitis	0.000397	0.00165	CcSEcCtD
Vemurafenib—Vomiting—Dimenhydrinate—atopic dermatitis	0.000392	0.00163	CcSEcCtD
Vemurafenib—Vomiting—Diphenhydramine—atopic dermatitis	0.000392	0.00163	CcSEcCtD
Vemurafenib—Dysgeusia—Tacrolimus—atopic dermatitis	0.000389	0.00162	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000388	0.00162	CcSEcCtD
Vemurafenib—Rash—Dimenhydrinate—atopic dermatitis	0.000388	0.00162	CcSEcCtD
Vemurafenib—Rash—Diphenhydramine—atopic dermatitis	0.000388	0.00162	CcSEcCtD
Vemurafenib—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000388	0.00162	CcSEcCtD
Vemurafenib—Dermatitis—Diphenhydramine—atopic dermatitis	0.000388	0.00162	CcSEcCtD
Vemurafenib—Dry skin—Prednisolone—atopic dermatitis	0.000386	0.00161	CcSEcCtD
Vemurafenib—Headache—Dimenhydrinate—atopic dermatitis	0.000386	0.00161	CcSEcCtD
Vemurafenib—Headache—Diphenhydramine—atopic dermatitis	0.000386	0.00161	CcSEcCtD
Vemurafenib—Back pain—Tacrolimus—atopic dermatitis	0.000384	0.0016	CcSEcCtD
Vemurafenib—Vomiting—Pimecrolimus—atopic dermatitis	0.000379	0.00158	CcSEcCtD
Vemurafenib—Dry skin—Hydrocortisone—atopic dermatitis	0.000377	0.00157	CcSEcCtD
Vemurafenib—Rash—Pimecrolimus—atopic dermatitis	0.000376	0.00156	CcSEcCtD
Vemurafenib—Dermatitis—Pimecrolimus—atopic dermatitis	0.000375	0.00156	CcSEcCtD
Vemurafenib—Body temperature increased—Loratadine—atopic dermatitis	0.000375	0.00156	CcSEcCtD
Vemurafenib—Headache—Pimecrolimus—atopic dermatitis	0.000373	0.00155	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000371	0.00155	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000368	0.00153	CcSEcCtD
Vemurafenib—Nausea—Dimenhydrinate—atopic dermatitis	0.000366	0.00152	CcSEcCtD
Vemurafenib—Nausea—Diphenhydramine—atopic dermatitis	0.000366	0.00152	CcSEcCtD
Vemurafenib—Decreased appetite—Mometasone—atopic dermatitis	0.000354	0.00147	CcSEcCtD
Vemurafenib—Nausea—Pimecrolimus—atopic dermatitis	0.000354	0.00147	CcSEcCtD
Vemurafenib—Fatigue—Mometasone—atopic dermatitis	0.000351	0.00146	CcSEcCtD
Vemurafenib—Cough—Tacrolimus—atopic dermatitis	0.000346	0.00144	CcSEcCtD
Vemurafenib—Asthenia—Loratadine—atopic dermatitis	0.00034	0.00142	CcSEcCtD
Vemurafenib—Myalgia—Tacrolimus—atopic dermatitis	0.000338	0.00141	CcSEcCtD
Vemurafenib—Arthralgia—Tacrolimus—atopic dermatitis	0.000338	0.00141	CcSEcCtD
Vemurafenib—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000337	0.0014	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000336	0.0014	CcSEcCtD
Vemurafenib—Diarrhoea—Loratadine—atopic dermatitis	0.000325	0.00135	CcSEcCtD
Vemurafenib—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000324	0.00135	CcSEcCtD
Vemurafenib—Dry skin—Dexamethasone—atopic dermatitis	0.000322	0.00134	CcSEcCtD
Vemurafenib—Dry skin—Betamethasone—atopic dermatitis	0.000322	0.00134	CcSEcCtD
Vemurafenib—Infection—Tacrolimus—atopic dermatitis	0.000322	0.00134	CcSEcCtD
Vemurafenib—Body temperature increased—Mometasone—atopic dermatitis	0.000322	0.00134	CcSEcCtD
Vemurafenib—Weight decreased—Hydrocortisone—atopic dermatitis	0.000322	0.00134	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Prednisolone—atopic dermatitis	0.000318	0.00133	CcSEcCtD
Vemurafenib—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000318	0.00132	CcSEcCtD
Vemurafenib—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000317	0.00132	CcSEcCtD
Vemurafenib—Infestation—Hydrocortisone—atopic dermatitis	0.000317	0.00132	CcSEcCtD
Vemurafenib—Skin disorder—Tacrolimus—atopic dermatitis	0.000315	0.00131	CcSEcCtD
Vemurafenib—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000314	0.00131	CcSEcCtD
Vemurafenib—Dizziness—Loratadine—atopic dermatitis	0.000314	0.00131	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Hydrocortisone—atopic dermatitis	0.000311	0.00129	CcSEcCtD
Vemurafenib—Hypotension—Tacrolimus—atopic dermatitis	0.000303	0.00126	CcSEcCtD
Vemurafenib—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000302	0.00126	CcSEcCtD
Vemurafenib—Vomiting—Loratadine—atopic dermatitis	0.000302	0.00126	CcSEcCtD
Vemurafenib—Rash—Loratadine—atopic dermatitis	0.000299	0.00125	CcSEcCtD
Vemurafenib—Dermatitis—Loratadine—atopic dermatitis	0.000299	0.00125	CcSEcCtD
Vemurafenib—Infestation—Methylprednisolone—atopic dermatitis	0.000298	0.00124	CcSEcCtD
Vemurafenib—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000298	0.00124	CcSEcCtD
Vemurafenib—Headache—Loratadine—atopic dermatitis	0.000297	0.00124	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000295	0.00123	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Triamcinolone—atopic dermatitis	0.000293	0.00122	CcSEcCtD
Vemurafenib—Asthenia—Mometasone—atopic dermatitis	0.000292	0.00122	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Methylprednisolone—atopic dermatitis	0.000292	0.00122	CcSEcCtD
Vemurafenib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000292	0.00122	CcSEcCtD
Vemurafenib—Pruritus—Mometasone—atopic dermatitis	0.000288	0.0012	CcSEcCtD
Vemurafenib—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000282	0.00117	CcSEcCtD
Vemurafenib—Nausea—Loratadine—atopic dermatitis	0.000282	0.00117	CcSEcCtD
Vemurafenib—Decreased appetite—Tacrolimus—atopic dermatitis	0.000282	0.00117	CcSEcCtD
Vemurafenib—Dry skin—Prednisone—atopic dermatitis	0.00028	0.00117	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00028	0.00117	CcSEcCtD
Vemurafenib—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00028	0.00116	CcSEcCtD
Vemurafenib—Fatigue—Tacrolimus—atopic dermatitis	0.000279	0.00116	CcSEcCtD
Vemurafenib—Diarrhoea—Mometasone—atopic dermatitis	0.000279	0.00116	CcSEcCtD
Vemurafenib—Constipation—Tacrolimus—atopic dermatitis	0.000277	0.00115	CcSEcCtD
Vemurafenib—Weight decreased—Betamethasone—atopic dermatitis	0.000275	0.00114	CcSEcCtD
Vemurafenib—Weight decreased—Dexamethasone—atopic dermatitis	0.000275	0.00114	CcSEcCtD
Vemurafenib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000271	0.00113	CcSEcCtD
Vemurafenib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000269	0.00112	CcSEcCtD
Vemurafenib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000269	0.00112	CcSEcCtD
Vemurafenib—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000267	0.00111	CcSEcCtD
Vemurafenib—Eye disorder—Hydrocortisone—atopic dermatitis	0.000266	0.00111	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.000265	0.00111	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.000265	0.00111	CcSEcCtD
Vemurafenib—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000263	0.00109	CcSEcCtD
Vemurafenib—Vomiting—Mometasone—atopic dermatitis	0.000259	0.00108	CcSEcCtD
Vemurafenib—Rash—Mometasone—atopic dermatitis	0.000257	0.00107	CcSEcCtD
Vemurafenib—Dermatitis—Mometasone—atopic dermatitis	0.000256	0.00107	CcSEcCtD
Vemurafenib—Body temperature increased—Tacrolimus—atopic dermatitis	0.000256	0.00107	CcSEcCtD
Vemurafenib—Headache—Mometasone—atopic dermatitis	0.000255	0.00106	CcSEcCtD
Vemurafenib—Erythema—Prednisolone—atopic dermatitis	0.000254	0.00106	CcSEcCtD
Vemurafenib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000253	0.00106	CcSEcCtD
Vemurafenib—Eye disorder—Methylprednisolone—atopic dermatitis	0.00025	0.00104	CcSEcCtD
Vemurafenib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000248	0.00103	CcSEcCtD
Vemurafenib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000248	0.00103	CcSEcCtD
Vemurafenib—Erythema—Hydrocortisone—atopic dermatitis	0.000248	0.00103	CcSEcCtD
Vemurafenib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000243	0.00101	CcSEcCtD
Vemurafenib—Nausea—Mometasone—atopic dermatitis	0.000242	0.00101	CcSEcCtD
Vemurafenib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000241	0.001	CcSEcCtD
Vemurafenib—Weight decreased—Prednisone—atopic dermatitis	0.000239	0.000997	CcSEcCtD
Vemurafenib—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000239	0.000995	CcSEcCtD
Vemurafenib—Erythema—Triamcinolone—atopic dermatitis	0.000233	0.000972	CcSEcCtD
Vemurafenib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000233	0.000969	CcSEcCtD
Vemurafenib—Erythema—Methylprednisolone—atopic dermatitis	0.000233	0.000969	CcSEcCtD
Vemurafenib—Asthenia—Tacrolimus—atopic dermatitis	0.000232	0.000969	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000231	0.000963	CcSEcCtD
Vemurafenib—Pruritus—Tacrolimus—atopic dermatitis	0.000229	0.000955	CcSEcCtD
Vemurafenib—Dysgeusia—Triamcinolone—atopic dermatitis	0.000228	0.000952	CcSEcCtD
Vemurafenib—Eye disorder—Betamethasone—atopic dermatitis	0.000227	0.000946	CcSEcCtD
Vemurafenib—Eye disorder—Dexamethasone—atopic dermatitis	0.000227	0.000946	CcSEcCtD
Vemurafenib—Back pain—Triamcinolone—atopic dermatitis	0.000226	0.00094	CcSEcCtD
Vemurafenib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000222	0.000924	CcSEcCtD
Vemurafenib—Angiopathy—Betamethasone—atopic dermatitis	0.000221	0.000919	CcSEcCtD
Vemurafenib—Angiopathy—Dexamethasone—atopic dermatitis	0.000221	0.000919	CcSEcCtD
Vemurafenib—Alopecia—Dexamethasone—atopic dermatitis	0.000215	0.000895	CcSEcCtD
Vemurafenib—Alopecia—Betamethasone—atopic dermatitis	0.000215	0.000895	CcSEcCtD
Vemurafenib—Dizziness—Tacrolimus—atopic dermatitis	0.000214	0.000893	CcSEcCtD
Vemurafenib—Erythema—Betamethasone—atopic dermatitis	0.000212	0.000882	CcSEcCtD
Vemurafenib—Erythema—Dexamethasone—atopic dermatitis	0.000212	0.000882	CcSEcCtD
Vemurafenib—Myalgia—Hydrocortisone—atopic dermatitis	0.000211	0.000879	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000209	0.000872	CcSEcCtD
Vemurafenib—Connective tissue disorder—Prednisone—atopic dermatitis	0.000208	0.000867	CcSEcCtD
Vemurafenib—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000207	0.000862	CcSEcCtD
Vemurafenib—Vomiting—Tacrolimus—atopic dermatitis	0.000206	0.000858	CcSEcCtD
Vemurafenib—Rash—Tacrolimus—atopic dermatitis	0.000204	0.000851	CcSEcCtD
Vemurafenib—Dermatitis—Tacrolimus—atopic dermatitis	0.000204	0.00085	CcSEcCtD
Vemurafenib—Cough—Triamcinolone—atopic dermatitis	0.000204	0.000848	CcSEcCtD
Vemurafenib—Headache—Tacrolimus—atopic dermatitis	0.000203	0.000846	CcSEcCtD
Vemurafenib—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000202	0.000842	CcSEcCtD
Vemurafenib—Infection—Hydrocortisone—atopic dermatitis	0.000201	0.000837	CcSEcCtD
Vemurafenib—Myalgia—Triamcinolone—atopic dermatitis	0.000199	0.000827	CcSEcCtD
Vemurafenib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000198	0.000826	CcSEcCtD
Vemurafenib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000198	0.000825	CcSEcCtD
Vemurafenib—Myalgia—Methylprednisolone—atopic dermatitis	0.000198	0.000825	CcSEcCtD
Vemurafenib—Eye disorder—Prednisone—atopic dermatitis	0.000198	0.000824	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000197	0.00082	CcSEcCtD
Vemurafenib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000196	0.000818	CcSEcCtD
Vemurafenib—Nausea—Tacrolimus—atopic dermatitis	0.000192	0.000802	CcSEcCtD
Vemurafenib—Angiopathy—Prednisone—atopic dermatitis	0.000192	0.0008	CcSEcCtD
Vemurafenib—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00019	0.000793	CcSEcCtD
Vemurafenib—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.00019	0.000791	CcSEcCtD
Vemurafenib—Infection—Triamcinolone—atopic dermatitis	0.000189	0.000788	CcSEcCtD
Vemurafenib—Hypotension—Hydrocortisone—atopic dermatitis	0.000189	0.000787	CcSEcCtD
Vemurafenib—Infection—Methylprednisolone—atopic dermatitis	0.000189	0.000786	CcSEcCtD
Vemurafenib—Alopecia—Prednisone—atopic dermatitis	0.000187	0.000779	CcSEcCtD
Vemurafenib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000186	0.000776	CcSEcCtD
Vemurafenib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000184	0.000769	CcSEcCtD
Vemurafenib—Malnutrition—Prednisone—atopic dermatitis	0.000184	0.000768	CcSEcCtD
Vemurafenib—Erythema—Prednisone—atopic dermatitis	0.000184	0.000768	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000184	0.000767	CcSEcCtD
Vemurafenib—Myalgia—Betamethasone—atopic dermatitis	0.00018	0.000751	CcSEcCtD
Vemurafenib—Myalgia—Dexamethasone—atopic dermatitis	0.00018	0.000751	CcSEcCtD
Vemurafenib—Hypotension—Methylprednisolone—atopic dermatitis	0.000177	0.000739	CcSEcCtD
Vemurafenib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000176	0.000732	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000175	0.000727	CcSEcCtD
Vemurafenib—Fatigue—Hydrocortisone—atopic dermatitis	0.000174	0.000726	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000173	0.000722	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000173	0.000721	CcSEcCtD
Vemurafenib—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000173	0.00072	CcSEcCtD
Vemurafenib—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000173	0.00072	CcSEcCtD
Vemurafenib—Infection—Dexamethasone—atopic dermatitis	0.000172	0.000715	CcSEcCtD
Vemurafenib—Infection—Betamethasone—atopic dermatitis	0.000172	0.000715	CcSEcCtD
Vemurafenib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000169	0.000706	CcSEcCtD
Vemurafenib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000169	0.000706	CcSEcCtD
Vemurafenib—Fatigue—Triamcinolone—atopic dermatitis	0.000164	0.000684	CcSEcCtD
Vemurafenib—Fatigue—Methylprednisolone—atopic dermatitis	0.000164	0.000682	CcSEcCtD
Vemurafenib—Hypotension—Dexamethasone—atopic dermatitis	0.000161	0.000672	CcSEcCtD
Vemurafenib—Hypotension—Betamethasone—atopic dermatitis	0.000161	0.000672	CcSEcCtD
Vemurafenib—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00016	0.000666	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000157	0.000656	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000157	0.000656	CcSEcCtD
Vemurafenib—Arthralgia—Prednisone—atopic dermatitis	0.000157	0.000654	CcSEcCtD
Vemurafenib—Myalgia—Prednisone—atopic dermatitis	0.000157	0.000654	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000156	0.000649	CcSEcCtD
Vemurafenib—Hypersensitivity—Prednisolone—atopic dermatitis	0.000152	0.000635	CcSEcCtD
Vemurafenib—Body temperature increased—Triamcinolone—atopic dermatitis	0.00015	0.000627	CcSEcCtD
Vemurafenib—Anaphylactic shock—Prednisone—atopic dermatitis	0.00015	0.000627	CcSEcCtD
Vemurafenib—Decreased appetite—Dexamethasone—atopic dermatitis	0.00015	0.000625	CcSEcCtD
Vemurafenib—Decreased appetite—Betamethasone—atopic dermatitis	0.00015	0.000625	CcSEcCtD
Vemurafenib—Infection—Prednisone—atopic dermatitis	0.000149	0.000623	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000149	0.000621	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000149	0.000621	CcSEcCtD
Vemurafenib—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000149	0.00062	CcSEcCtD
Vemurafenib—Fatigue—Dexamethasone—atopic dermatitis	0.000149	0.00062	CcSEcCtD
Vemurafenib—Fatigue—Betamethasone—atopic dermatitis	0.000149	0.00062	CcSEcCtD
Vemurafenib—Nervous system disorder—Prednisone—atopic dermatitis	0.000148	0.000615	CcSEcCtD
Vemurafenib—Skin disorder—Prednisone—atopic dermatitis	0.000146	0.000609	CcSEcCtD
Vemurafenib—Asthenia—Hydrocortisone—atopic dermatitis	0.000145	0.000604	CcSEcCtD
Vemurafenib—Pruritus—Hydrocortisone—atopic dermatitis	0.000143	0.000596	CcSEcCtD
Vemurafenib—Hypersensitivity—Triamcinolone—atopic dermatitis	0.00014	0.000584	CcSEcCtD
Vemurafenib—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00014	0.000583	CcSEcCtD
Vemurafenib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000138	0.000576	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000137	0.000571	CcSEcCtD
Vemurafenib—Dizziness—Prednisolone—atopic dermatitis	0.000137	0.00057	CcSEcCtD
Vemurafenib—Asthenia—Triamcinolone—atopic dermatitis	0.000137	0.000569	CcSEcCtD
Vemurafenib—Body temperature increased—Dexamethasone—atopic dermatitis	0.000137	0.000569	CcSEcCtD
Vemurafenib—Body temperature increased—Betamethasone—atopic dermatitis	0.000137	0.000569	CcSEcCtD
Vemurafenib—Asthenia—Methylprednisolone—atopic dermatitis	0.000136	0.000568	CcSEcCtD
Vemurafenib—Pruritus—Triamcinolone—atopic dermatitis	0.000135	0.000561	CcSEcCtD
Vemurafenib—Pruritus—Methylprednisolone—atopic dermatitis	0.000134	0.00056	CcSEcCtD
Vemurafenib—Dizziness—Hydrocortisone—atopic dermatitis	0.000134	0.000557	CcSEcCtD
Vemurafenib—Decreased appetite—Prednisone—atopic dermatitis	0.000131	0.000545	CcSEcCtD
Vemurafenib—Rash—Prednisolone—atopic dermatitis	0.000131	0.000544	CcSEcCtD
Vemurafenib—Dermatitis—Prednisolone—atopic dermatitis	0.00013	0.000543	CcSEcCtD
Vemurafenib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00013	0.000541	CcSEcCtD
Vemurafenib—Fatigue—Prednisone—atopic dermatitis	0.00013	0.00054	CcSEcCtD
Vemurafenib—Headache—Prednisolone—atopic dermatitis	0.00013	0.00054	CcSEcCtD
Vemurafenib—RAF1—Adaptive Immune System—KIF3A—atopic dermatitis	0.000129	0.0017	CbGpPWpGaD
Vemurafenib—Constipation—Prednisone—atopic dermatitis	0.000129	0.000536	CcSEcCtD
Vemurafenib—Vomiting—Hydrocortisone—atopic dermatitis	0.000129	0.000535	CcSEcCtD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—CXCL8—atopic dermatitis	0.000128	0.00169	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000128	0.00169	CbGpPWpGaD
Vemurafenib—Rash—Hydrocortisone—atopic dermatitis	0.000127	0.000531	CcSEcCtD
Vemurafenib—Dermatitis—Hydrocortisone—atopic dermatitis	0.000127	0.000531	CcSEcCtD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	0.000127	0.00168	CbGpPWpGaD
Vemurafenib—Headache—Hydrocortisone—atopic dermatitis	0.000127	0.000528	CcSEcCtD
Vemurafenib—Dizziness—Triamcinolone—atopic dermatitis	0.000126	0.000524	CcSEcCtD
Vemurafenib—Dizziness—Methylprednisolone—atopic dermatitis	0.000126	0.000523	CcSEcCtD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	0.000125	0.00166	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	0.000125	0.00166	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GLB1—atopic dermatitis	0.000125	0.00165	CbGpPWpGaD
Vemurafenib—Asthenia—Betamethasone—atopic dermatitis	0.000124	0.000516	CcSEcCtD
Vemurafenib—Asthenia—Dexamethasone—atopic dermatitis	0.000124	0.000516	CcSEcCtD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—IL1B—atopic dermatitis	0.000123	0.00162	CbGpPWpGaD
Vemurafenib—Nausea—Prednisolone—atopic dermatitis	0.000123	0.000512	CcSEcCtD
Vemurafenib—Pruritus—Betamethasone—atopic dermatitis	0.000122	0.000509	CcSEcCtD
Vemurafenib—Pruritus—Dexamethasone—atopic dermatitis	0.000122	0.000509	CcSEcCtD
Vemurafenib—BRAF—MAPK Signaling Pathway—IL1B—atopic dermatitis	0.000122	0.00161	CbGpPWpGaD
Vemurafenib—Vomiting—Triamcinolone—atopic dermatitis	0.000121	0.000504	CcSEcCtD
Vemurafenib—Vomiting—Methylprednisolone—atopic dermatitis	0.000121	0.000503	CcSEcCtD
Vemurafenib—RAF1—Hemostasis—SELE—atopic dermatitis	0.00012	0.00159	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL1B—atopic dermatitis	0.00012	0.00159	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL22—atopic dermatitis	0.00012	0.00159	CbGpPWpGaD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—MAPK8—atopic dermatitis	0.00012	0.00159	CbGpPWpGaD
Vemurafenib—Nausea—Hydrocortisone—atopic dermatitis	0.00012	0.0005	CcSEcCtD
Vemurafenib—Rash—Triamcinolone—atopic dermatitis	0.00012	0.0005	CcSEcCtD
Vemurafenib—Dermatitis—Triamcinolone—atopic dermatitis	0.00012	0.0005	CcSEcCtD
Vemurafenib—RAF1—Signaling by Interleukins—IL2—atopic dermatitis	0.00012	0.00158	CbGpPWpGaD
Vemurafenib—Rash—Methylprednisolone—atopic dermatitis	0.00012	0.000499	CcSEcCtD
Vemurafenib—Dermatitis—Methylprednisolone—atopic dermatitis	0.00012	0.000498	CcSEcCtD
Vemurafenib—Headache—Triamcinolone—atopic dermatitis	0.000119	0.000497	CcSEcCtD
Vemurafenib—Headache—Methylprednisolone—atopic dermatitis	0.000119	0.000496	CcSEcCtD
Vemurafenib—Body temperature increased—Prednisone—atopic dermatitis	0.000119	0.000495	CcSEcCtD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NFKBIA—atopic dermatitis	0.000118	0.00156	CbGpPWpGaD
Vemurafenib—Diarrhoea—Betamethasone—atopic dermatitis	0.000118	0.000492	CcSEcCtD
Vemurafenib—Diarrhoea—Dexamethasone—atopic dermatitis	0.000118	0.000492	CcSEcCtD
Vemurafenib—RAF1—Immune System—FCER1A—atopic dermatitis	0.000118	0.00156	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000118	0.00156	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—NFKBIA—atopic dermatitis	0.000117	0.00154	CbGpPWpGaD
Vemurafenib—RAF1—SHP2 signaling—IL6—atopic dermatitis	0.000116	0.00153	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000115	0.00152	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—STAT6—atopic dermatitis	0.000114	0.00151	CbGpPWpGaD
Vemurafenib—Dizziness—Betamethasone—atopic dermatitis	0.000114	0.000476	CcSEcCtD
Vemurafenib—Dizziness—Dexamethasone—atopic dermatitis	0.000114	0.000476	CcSEcCtD
Vemurafenib—Nausea—Triamcinolone—atopic dermatitis	0.000113	0.000471	CcSEcCtD
Vemurafenib—RAF1—ErbB1 downstream signaling—MAPK8—atopic dermatitis	0.000113	0.00149	CbGpPWpGaD
Vemurafenib—Nausea—Methylprednisolone—atopic dermatitis	0.000113	0.00047	CcSEcCtD
Vemurafenib—BRAF—MAPK Signaling Pathway—MAPK8—atopic dermatitis	0.000112	0.00148	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000111	0.00147	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—CASP8—atopic dermatitis	0.000111	0.00147	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CARD11—atopic dermatitis	0.000111	0.00147	CbGpPWpGaD
Vemurafenib—Hypersensitivity—Prednisone—atopic dermatitis	0.000111	0.000462	CcSEcCtD
Vemurafenib—BRAF—Signaling Pathways—FCER2—atopic dermatitis	0.00011	0.00146	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MS4A2—atopic dermatitis	0.00011	0.00145	CbGpPWpGaD
Vemurafenib—Vomiting—Dexamethasone—atopic dermatitis	0.00011	0.000457	CcSEcCtD
Vemurafenib—Vomiting—Betamethasone—atopic dermatitis	0.00011	0.000457	CcSEcCtD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000109	0.00144	CbGpPWpGaD
Vemurafenib—Rash—Dexamethasone—atopic dermatitis	0.000109	0.000454	CcSEcCtD
Vemurafenib—Rash—Betamethasone—atopic dermatitis	0.000109	0.000454	CcSEcCtD
Vemurafenib—Dermatitis—Betamethasone—atopic dermatitis	0.000109	0.000453	CcSEcCtD
Vemurafenib—Dermatitis—Dexamethasone—atopic dermatitis	0.000109	0.000453	CcSEcCtD
Vemurafenib—Headache—Betamethasone—atopic dermatitis	0.000108	0.000451	CcSEcCtD
Vemurafenib—Headache—Dexamethasone—atopic dermatitis	0.000108	0.000451	CcSEcCtD
Vemurafenib—Asthenia—Prednisone—atopic dermatitis	0.000108	0.00045	CcSEcCtD
Vemurafenib—ALB—Folate Metabolism—IFNG—atopic dermatitis	0.000108	0.00142	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL18—atopic dermatitis	0.000107	0.00142	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL27—atopic dermatitis	0.000107	0.00141	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CARD11—atopic dermatitis	0.000107	0.00141	CbGpPWpGaD
Vemurafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	0.000107	0.00141	CbGpPWpGaD
Vemurafenib—Pruritus—Prednisone—atopic dermatitis	0.000106	0.000443	CcSEcCtD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	0.000104	0.00137	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000103	0.00136	CbGpPWpGaD
Vemurafenib—Diarrhoea—Prednisone—atopic dermatitis	0.000103	0.000429	CcSEcCtD
Vemurafenib—BRAF—Signaling Pathways—CCL22—atopic dermatitis	0.000103	0.00136	CbGpPWpGaD
Vemurafenib—Nausea—Betamethasone—atopic dermatitis	0.000103	0.000427	CcSEcCtD
Vemurafenib—Nausea—Dexamethasone—atopic dermatitis	0.000103	0.000427	CcSEcCtD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000102	0.00135	CbGpPWpGaD
Vemurafenib—RAF1—NCAM signaling for neurite out-growth—IL6—atopic dermatitis	0.000102	0.00135	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—MAPK8—atopic dermatitis	0.000101	0.00134	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000101	0.00133	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000101	0.00133	CbGpPWpGaD
Vemurafenib—Dizziness—Prednisone—atopic dermatitis	9.95e-05	0.000414	CcSEcCtD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—TNF—atopic dermatitis	9.92e-05	0.00131	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	9.81e-05	0.0013	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—DEFB1—atopic dermatitis	9.79e-05	0.00129	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—NGF—atopic dermatitis	9.78e-05	0.00129	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL17—atopic dermatitis	9.61e-05	0.00127	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL1B—atopic dermatitis	9.6e-05	0.00127	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL2—atopic dermatitis	9.57e-05	0.00126	CbGpPWpGaD
Vemurafenib—Vomiting—Prednisone—atopic dermatitis	9.56e-05	0.000398	CcSEcCtD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	9.52e-05	0.00126	CbGpPWpGaD
Vemurafenib—Rash—Prednisone—atopic dermatitis	9.48e-05	0.000395	CcSEcCtD
Vemurafenib—Dermatitis—Prednisone—atopic dermatitis	9.47e-05	0.000395	CcSEcCtD
Vemurafenib—Headache—Prednisone—atopic dermatitis	9.42e-05	0.000393	CcSEcCtD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—MAPK8—atopic dermatitis	9.4e-05	0.00124	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL27—atopic dermatitis	9.15e-05	0.00121	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL5—atopic dermatitis	9.12e-05	0.0012	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	9.01e-05	0.00119	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	8.97e-05	0.00118	CbGpPWpGaD
Vemurafenib—Nausea—Prednisone—atopic dermatitis	8.93e-05	0.000372	CcSEcCtD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	8.93e-05	0.00118	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TNF—atopic dermatitis	8.86e-05	0.00117	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—MAPK8—atopic dermatitis	8.76e-05	0.00116	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.73e-05	0.00115	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CASP1—atopic dermatitis	8.66e-05	0.00114	CbGpPWpGaD
Vemurafenib—RAF1—Disease—GLB1—atopic dermatitis	8.62e-05	0.00114	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	8.56e-05	0.00113	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	8.55e-05	0.00113	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GLB1—atopic dermatitis	8.55e-05	0.00113	CbGpPWpGaD
Vemurafenib—RAF1—IRS-mediated signalling—IL6—atopic dermatitis	8.53e-05	0.00113	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—IL1B—atopic dermatitis	8.45e-05	0.00112	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SLC11A1—atopic dermatitis	8.35e-05	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events—IL6—atopic dermatitis	8.3e-05	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events triggered by IGF1R—IL6—atopic dermatitis	8.22e-05	0.00109	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL17—atopic dermatitis	8.21e-05	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—IL6—atopic dermatitis	8.15e-05	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—NFKBIA—atopic dermatitis	8.07e-05	0.00107	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—MAPK8—atopic dermatitis	8.06e-05	0.00106	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—KIF3A—atopic dermatitis	8.03e-05	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—Insulin receptor signalling cascade—IL6—atopic dermatitis	8.01e-05	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—IGF1R signaling cascade—IL6—atopic dermatitis	8.01e-05	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—IL6—atopic dermatitis	8.01e-05	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	7.98e-05	0.00105	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TLR2—atopic dermatitis	7.83e-05	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—KIF3A—atopic dermatitis	7.83e-05	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL11—atopic dermatitis	7.75e-05	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—MAPK8—atopic dermatitis	7.75e-05	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FCER2—atopic dermatitis	7.64e-05	0.00101	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	7.63e-05	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	7.43e-05	0.000981	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—IL6—atopic dermatitis	7.36e-05	0.000972	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—MAPK8—atopic dermatitis	7.32e-05	0.000966	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—KIF3A—atopic dermatitis	7.31e-05	0.000966	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	7.21e-05	0.000951	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GLB1—atopic dermatitis	7.16e-05	0.000945	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL22—atopic dermatitis	7.1e-05	0.000938	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	7.1e-05	0.000937	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD79A—atopic dermatitis	7.07e-05	0.000934	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL6—atopic dermatitis	7.05e-05	0.00093	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—MAPK8—atopic dermatitis	7.02e-05	0.000927	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	6.99e-05	0.000923	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TNF—atopic dermatitis	6.97e-05	0.00092	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	6.91e-05	0.000912	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADSL—atopic dermatitis	6.86e-05	0.000906	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—IL6—atopic dermatitis	6.86e-05	0.000905	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	6.76e-05	0.000892	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—IL6—atopic dermatitis	6.7e-05	0.000885	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—STAT6—atopic dermatitis	6.66e-05	0.000879	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—IL6—atopic dermatitis	6.65e-05	0.000878	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL11—atopic dermatitis	6.62e-05	0.000873	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CMA1—atopic dermatitis	6.62e-05	0.000873	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	6.51e-05	0.000859	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	6.51e-05	0.000859	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—SELE—atopic dermatitis	6.48e-05	0.000855	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CARD11—atopic dermatitis	6.47e-05	0.000855	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL27—atopic dermatitis	6.33e-05	0.000836	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCR3—atopic dermatitis	6.32e-05	0.000834	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GLB1—atopic dermatitis	6.3e-05	0.000832	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	6.29e-05	0.000831	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—STAT6—atopic dermatitis	6.22e-05	0.000821	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TNF—atopic dermatitis	6.13e-05	0.000809	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.11e-05	0.000806	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	6.07e-05	0.000802	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADSL—atopic dermatitis	6.04e-05	0.000797	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—PPARA—atopic dermatitis	5.89e-05	0.000778	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SLC11A1—atopic dermatitis	5.78e-05	0.000763	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SLC11A1—atopic dermatitis	5.73e-05	0.000756	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD8A—atopic dermatitis	5.7e-05	0.000752	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—IL6—atopic dermatitis	5.69e-05	0.000751	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL17—atopic dermatitis	5.68e-05	0.00075	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—NPS—atopic dermatitis	5.63e-05	0.000743	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—TAC1—atopic dermatitis	5.63e-05	0.000743	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL6—atopic dermatitis	5.62e-05	0.000742	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	5.61e-05	0.000741	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL2—atopic dermatitis	5.59e-05	0.000738	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.56e-05	0.000734	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	5.54e-05	0.000731	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.53e-05	0.00073	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCR3—atopic dermatitis	5.52e-05	0.000729	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—IL6—atopic dermatitis	5.45e-05	0.000719	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCR3—atopic dermatitis	5.39e-05	0.000712	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—IL6—atopic dermatitis	5.36e-05	0.000708	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL5—atopic dermatitis	5.23e-05	0.000691	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.22e-05	0.000689	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—IL6—atopic dermatitis	5.12e-05	0.000676	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—IL6—atopic dermatitis	5.09e-05	0.000672	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—IL6—atopic dermatitis	5.07e-05	0.000669	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—MAPK8—atopic dermatitis	5.06e-05	0.000668	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—KIF3A—atopic dermatitis	5.06e-05	0.000668	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CASP1—atopic dermatitis	5.04e-05	0.000666	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—IL6—atopic dermatitis	5.04e-05	0.000666	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5e-05	0.000661	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.96e-05	0.000655	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL5—atopic dermatitis	4.91e-05	0.000648	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NPS—atopic dermatitis	4.81e-05	0.000635	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TAC1—atopic dermatitis	4.81e-05	0.000635	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL5—atopic dermatitis	4.78e-05	0.000631	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—IL6—atopic dermatitis	4.75e-05	0.000626	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—IL6—atopic dermatitis	4.75e-05	0.000626	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	4.75e-05	0.000626	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCR3—atopic dermatitis	4.71e-05	0.000622	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—IL6—atopic dermatitis	4.7e-05	0.000621	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—IL6—atopic dermatitis	4.67e-05	0.000617	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—IL6—atopic dermatitis	4.66e-05	0.000615	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—IL6—atopic dermatitis	4.64e-05	0.000613	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—NFKBIA—atopic dermatitis	4.6e-05	0.000608	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL11—atopic dermatitis	4.58e-05	0.000604	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CMA1—atopic dermatitis	4.58e-05	0.000604	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR2—atopic dermatitis	4.56e-05	0.000602	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL5—atopic dermatitis	4.47e-05	0.00059	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	4.47e-05	0.00059	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL10—atopic dermatitis	4.46e-05	0.000589	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—NFKBIA—atopic dermatitis	4.42e-05	0.000583	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.37e-05	0.000576	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—STAT6—atopic dermatitis	4.3e-05	0.000568	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD79A—atopic dermatitis	4.29e-05	0.000566	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CCR5—atopic dermatitis	4.22e-05	0.000557	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	4.2e-05	0.000555	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CASP8—atopic dermatitis	4.15e-05	0.000548	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.06e-05	0.000536	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GLB1—atopic dermatitis	3.89e-05	0.000513	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL5—atopic dermatitis	3.84e-05	0.000507	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL10—atopic dermatitis	3.81e-05	0.000503	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR3—atopic dermatitis	3.73e-05	0.000493	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADSL—atopic dermatitis	3.73e-05	0.000492	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	3.64e-05	0.00048	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL18—atopic dermatitis	3.51e-05	0.000463	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL2—atopic dermatitis	3.48e-05	0.00046	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCR5—atopic dermatitis	3.46e-05	0.000457	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD8A—atopic dermatitis	3.46e-05	0.000456	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD4—atopic dermatitis	3.41e-05	0.00045	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TAC1—atopic dermatitis	3.33e-05	0.000439	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NPS—atopic dermatitis	3.33e-05	0.000439	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	3.29e-05	0.000434	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL5—atopic dermatitis	3.28e-05	0.000433	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD4—atopic dermatitis	3.27e-05	0.000432	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCR3—atopic dermatitis	3.26e-05	0.000431	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—IL6—atopic dermatitis	3.23e-05	0.000427	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GLB1—atopic dermatitis	3.21e-05	0.000424	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL5—atopic dermatitis	3.09e-05	0.000408	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADSL—atopic dermatitis	3.08e-05	0.000406	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NGF—atopic dermatitis	3.04e-05	0.000401	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCR5—atopic dermatitis	2.95e-05	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—IL6—atopic dermatitis	2.93e-05	0.000386	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CCR5—atopic dermatitis	2.92e-05	0.000385	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CCR5—atopic dermatitis	2.89e-05	0.000382	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—MAPK8—atopic dermatitis	2.89e-05	0.000381	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.83e-05	0.000374	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GLB1—atopic dermatitis	2.72e-05	0.000359	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.69e-05	0.000356	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NFKBIA—atopic dermatitis	2.68e-05	0.000354	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD4—atopic dermatitis	2.65e-05	0.00035	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL10—atopic dermatitis	2.64e-05	0.000348	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADSL—atopic dermatitis	2.61e-05	0.000344	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—atopic dermatitis	2.59e-05	0.000342	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NFKBIA—atopic dermatitis	2.5e-05	0.000331	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CASP8—atopic dermatitis	2.42e-05	0.000319	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPARA—atopic dermatitis	2.32e-05	0.000307	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL5—atopic dermatitis	2.27e-05	0.0003	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NGF—atopic dermatitis	2.1e-05	0.000277	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.1e-05	0.000277	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL8—atopic dermatitis	2.09e-05	0.000276	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—atopic dermatitis	2.09e-05	0.000276	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNG—atopic dermatitis	2.06e-05	0.000271	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPARA—atopic dermatitis	2.04e-05	0.00027	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR5—atopic dermatitis	2.04e-05	0.00027	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.01e-05	0.000266	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2—atopic dermatitis	2e-05	0.000264	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD4—atopic dermatitis	1.99e-05	0.000262	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.98e-05	0.000262	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2—atopic dermatitis	1.88e-05	0.000248	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—atopic dermatitis	1.84e-05	0.000243	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL1B—atopic dermatitis	1.83e-05	0.000242	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD4—atopic dermatitis	1.83e-05	0.000242	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2—atopic dermatitis	1.83e-05	0.000241	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD4—atopic dermatitis	1.82e-05	0.00024	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL8—atopic dermatitis	1.79e-05	0.000236	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NFKBIA—atopic dermatitis	1.73e-05	0.000229	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2—atopic dermatitis	1.71e-05	0.000225	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MAPK8—atopic dermatitis	1.68e-05	0.000222	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAPK8—atopic dermatitis	1.57e-05	0.000207	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—atopic dermatitis	1.43e-05	0.000189	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARA—atopic dermatitis	1.26e-05	0.000167	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL8—atopic dermatitis	1.24e-05	0.000163	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2—atopic dermatitis	1.18e-05	0.000156	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—atopic dermatitis	1.18e-05	0.000155	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAPK8—atopic dermatitis	1.09e-05	0.000144	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—atopic dermatitis	1.07e-05	0.000142	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.04e-05	0.000138	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—atopic dermatitis	1e-05	0.000132	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—atopic dermatitis	9.91e-06	0.000131	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—atopic dermatitis	9.83e-06	0.00013	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARA—atopic dermatitis	8.82e-06	0.000116	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—atopic dermatitis	6.94e-06	9.17e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARA—atopic dermatitis	6.81e-06	8.99e-05	CbGpPWpGaD
